Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2026.04.16
海普瑞：关于举办2025年度业绩说明会的公告
2026.03.31
海普瑞：商誉减值测试报告
2026.03.31
海普瑞：关于召开2025年度股东会的通知
2026.03.31
海普瑞：关于续聘会计师事务所的公告
2026.03.31
海普瑞：关于使用自有资金购买理财产品及进行现金管理的公告
2026.03.31
海普瑞：关于开展以套期保值为目的的外汇衍生品交易的公告
2026.03.31
海普瑞：关于董事会换届选举的公告
2026.03.31
海普瑞：关于变更H股募集资金使用用途的公告
2026.03.31
海普瑞：关于2026年度向银行申请授信额度暨提供担保的公告
2026.03.31
海普瑞：关于2025年度利润分配预案的公告
第一页
上一页
1
2
3
4
5
下一页
最后一页
